Weekly Tech+Bio Highlights #65: Can AI Infrastructure Become Biotech’s Next Big Business?

2025 Pharma Review, Lilly Exec Explains Rationale Behind TuneLab AI Model Sharing & Biweekly News Roundup

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: